Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Lipodystrophy, Congenital Generalized

1-anilino-8-naphthalenesulfonate has been researched along with Lipodystrophy, Congenital Generalized in 2 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Lipodystrophy, Congenital Generalized: Congenital disorders, usually autosomal recessive, characterized by severe generalized lack of ADIPOSE TISSUE, extreme INSULIN RESISTANCE, and HYPERTRIGLYCERIDEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fukaishi, T1
Minami, I1
Masuda, S1
Miyachi, Y1
Tsujimoto, K1
Izumiyama, H1
Hashimoto, K1
Yoshida, M1
Takahashi, S1
Kashimada, K1
Morio, T1
Kosaki, K1
Maezawa, Y1
Yokote, K1
Yoshimoto, T1
Yamada, T1
Zhou, H1
Lei, X1
Yan, Y1
Lydic, T1
Li, J1
Weintraub, NL1
Su, H1
Chen, W1

Other Studies

2 other studies available for 1-anilino-8-naphthalenesulfonate and Lipodystrophy, Congenital Generalized

ArticleYear
A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
    Endocrine journal, 2020, Feb-28, Volume: 67, Issue:2

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus; Dyslipid

2020
Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
    JCI insight, 2019, 06-11, Volume: 5

    Topics: Adipocytes; Adipose Tissue; Animals; Cardiomyopathies; Cell Differentiation; Disease Models, Animal;

2019